Interventional Neuroradiology最新文献

筛选
英文 中文
Letter to the editor re: Sathya A, Nguyen TN, Klein P, et al. Endovascular vs surgical treatment of sigmoid sinus diverticulum causing pulsatile tinnitus: A systematic review. Interv Neuroradiol. 2024 Mar 22:15910199241231325. 致编辑的信re: Sathya A, Nguyen TN, Klein P,等。乙状窦憩室引起搏动性耳鸣的血管内vs手术治疗:系统回顾。神经放射学杂志,2024年3月22日:15910199241231325。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-10-17 DOI: 10.1177/15910199241290846
David J Eisenman, Dheeraj Ghandi, Yue-Lin Hsieh, Prashant Raghavan, Jae-Jin Song, Wuqing Wang
{"title":"Letter to the editor re: Sathya A, Nguyen TN, Klein P, et al. Endovascular vs surgical treatment of sigmoid sinus diverticulum causing pulsatile tinnitus: A systematic review. Interv Neuroradiol. 2024 Mar 22:15910199241231325.","authors":"David J Eisenman, Dheeraj Ghandi, Yue-Lin Hsieh, Prashant Raghavan, Jae-Jin Song, Wuqing Wang","doi":"10.1177/15910199241290846","DOIUrl":"10.1177/15910199241290846","url":null,"abstract":"<p><p>Letter to the Editor re: Sathya A, Nguyen TN, Klein P, et al. Endovascular vs surgical treatment of sigmoid sinus diverticulum causing pulsatile tinnitus: A systematic review. Interv Neuroradiol. 2024 Mar 22:15910199241231325.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":"32 4","pages":"2038-2040"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148674395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter study of the efficacy and safety of treatments (endovascular or conservative) in small intracranial aneurysms in Colombia. 一项关于哥伦比亚颅内小动脉瘤治疗(血管内治疗或保守治疗)的有效性和安全性的多中心研究。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-05-15 DOI: 10.1177/15910199241254138
Ana Beatriz Villamizar, María Fernanda Estévez, Oliverio Vargas, Carlos Andres Ferreira, Juan Andres Mejia, José David Cardona, Sergio Eduardo Serrano, Adriana Lucia Reyes, Daniel Eduardo Mantilla
{"title":"A multicenter study of the efficacy and safety of treatments (endovascular or conservative) in small intracranial aneurysms in Colombia.","authors":"Ana Beatriz Villamizar, María Fernanda Estévez, Oliverio Vargas, Carlos Andres Ferreira, Juan Andres Mejia, José David Cardona, Sergio Eduardo Serrano, Adriana Lucia Reyes, Daniel Eduardo Mantilla","doi":"10.1177/15910199241254138","DOIUrl":"10.1177/15910199241254138","url":null,"abstract":"<p><p>BackgroundThe registry of cerebral aneurysms <5 mm, known for their low risk of rupture, is significant, given their high incidence globally. Our study aimed to identify, in small aneurysms (<5 mm), the potential morphological characteristics, risk factors that can predict the risk of rupture, and the risk or benefit of treating them with endovascular or conservative treatment in ruptured and unruptured intracranial aneurysms.MethodsThe medical records of patients with cerebral aneurysms <5 mm were retrospectively reviewed between January 2014 and December 2022 at two neurovascular centers in Colombia. We evaluated clinical and angiographic outcomes using statistical tests.ResultsTwo hundred fifty-six patients (425 intracranial aneurysms) were registered in the database. Two hundred and seventy-five IA were treated with endovascular treatment: 70 ruptured aneurysms and 205 unruptured aneurysms. One hundred fifty intracranial aneurysms underwent conservative treatment (follow-up). Women accounted for 82.1% of cases. Most cases were incidentally diagnosed (83.5%). After a year of follow-up, 87.3% of unruptured and 67.1% of ruptured intracranial aneurysms had an mRS 0-2. In the Raymond-Roy occlusion classification, among 101 unruptured intracranial aneurysms embolized were 53 cases class I, and among 66 ruptured intracranial aneurysms embolized, 67.1% were class I.ConclusionEndovascular therapy for aneurysms <5 mm appears to be a technically feasible treatment, with satisfactory occlusion rates and few re-treatments at the 12-month follow-up. The complication rates were similar to those reported in studies on small aneurysms.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1491-1497"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140946317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of pipeline embolization device and flow redirection endoluminal device in the treatment of intracranial aneurysms: A systematic review and meta-analysis. 管道栓塞装置与血流重定向腔内装置在治疗颅内动脉瘤方面的比较:系统回顾和荟萃分析。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-07-25 DOI: 10.1177/15910199241264345
Basel Musmar, Atakan Orscelik, Hamza Salim, Fares Musmar, Nimer Adeeb, Kareem El Naamani, Muhammed Amir Essibayi, Samantha Spellicy, Jihad Abdelgadir, Adam A Dmytriw, Aman B Patel, Vitor Mendes Pereira, Hugo H Cuellar-Saenz, Bharat Guthikonda, Ali Zomorodi, Pascal Jabbour, David Hasan
{"title":"Comparison of pipeline embolization device and flow redirection endoluminal device in the treatment of intracranial aneurysms: A systematic review and meta-analysis.","authors":"Basel Musmar, Atakan Orscelik, Hamza Salim, Fares Musmar, Nimer Adeeb, Kareem El Naamani, Muhammed Amir Essibayi, Samantha Spellicy, Jihad Abdelgadir, Adam A Dmytriw, Aman B Patel, Vitor Mendes Pereira, Hugo H Cuellar-Saenz, Bharat Guthikonda, Ali Zomorodi, Pascal Jabbour, David Hasan","doi":"10.1177/15910199241264345","DOIUrl":"10.1177/15910199241264345","url":null,"abstract":"<p><p>BackgroundAdvancements in flow diversion technology have revolutionized the treatment of intracranial aneurysms. The pipeline embolization device (PED) and the flow redirection endoluminal device (FRED) have emerged as prominent tools in this field. This study aims to compare the safety and efficacy profiles of PED and FRED in the treatment of intracranial aneurysms.MethodsFollowing the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was conducted across PubMed, Web of Science, and Scopus databases. Studies comparing PED and FRED were included and data extraction focused on study characteristics, patient demographics, and clinical and radiological outcomes. Primary outcomes were favorable outcomes, described as modified Rankin scale (mRS) 0-2 score, and complete/near-complete occlusion, while secondary outcomes included retreatment rate and thromboembolic and hemorrhagic complications.ResultsFive studies, comprising 1238 patients, were included. No significant differences were found between PED and FRED in terms of complete occlusion at 6 months and 1 year, complete/near-complete occlusion at the last follow up, retreatment rates, and thromboembolic, in-stent thrombosis and hemorrhagic complications. However, FRED was significantly associated with higher favorable outcomes compared to PED (odds ratio: 0.37; confidence interval: 0.17 to 0.81; p = 0.01).ConclusionThis study showed that both PED and FRED had comparable rates of complete occlusion, retreatment and complications, and FRED also demonstrated a higher likelihood of achieving favorable outcomes. The study underscores the need for further research with larger cohorts and longer follow up to consolidate these findings.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1691-1699"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Interventional Neuroradiology: "How I Do It" v. I - Diagnostic Angiography. 小儿介入神经放射学:"我是怎么做的 "V. I - 血管造影诊断。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-05-27 DOI: 10.1177/15910199241255154
Jesse Jones, John Deveikis
{"title":"Pediatric Interventional Neuroradiology: \"How I Do It\" v. I - Diagnostic Angiography.","authors":"Jesse Jones, John Deveikis","doi":"10.1177/15910199241255154","DOIUrl":"10.1177/15910199241255154","url":null,"abstract":"<p><p>Pediatric neurointervention differs from the adult in several important respects. Here we describe a modern approach to readily acquire diagnostic quality images of children. Preparation, access, angiogragraphy and closure have evolved along with new knowledge and technology. This timely \"how I do it\" series addresses each topic utilizing literature review and our own experience over 35 years.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1518-1522"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of angiographic resolution in patients with presumed reversible cerebral vasoconstriction syndrome. 假定可逆性脑血管收缩综合征患者血管造影检查结果缓解的预测因素。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-03-05 DOI: 10.1177/15910199241237584
Adrusht Madapoosi, Laura Stone McGuire, Jessica Hossa, Angelica Fuentes, Mpuekela Tshibangu, Peter Theiss, Sepideh Amin-Hanjani, Ali Alaraj
{"title":"Predictors of angiographic resolution in patients with presumed reversible cerebral vasoconstriction syndrome.","authors":"Adrusht Madapoosi, Laura Stone McGuire, Jessica Hossa, Angelica Fuentes, Mpuekela Tshibangu, Peter Theiss, Sepideh Amin-Hanjani, Ali Alaraj","doi":"10.1177/15910199241237584","DOIUrl":"10.1177/15910199241237584","url":null,"abstract":"<p><p>IntroductionReversible cerebral vasoconstriction syndrome is a complex neurovascular syndrome that presents with varying neurological deficits as well as segmental vasoconstriction of the small and medium cerebral arteries. There is limited literature on pathologies that mimic reversible cerebral vasoconstriction syndrome, so this study aims to understand what factors may impact the angiographic confirmation of reversible cerebral vasoconstriction syndrome on follow-up and play a role in establishing the diagnosis.MethodsThe Clinical Research Data Warehouse at this institution was employed to search the medical records for patients with diagnosis and treatment of reversible cerebral vasoconstriction syndrome between January 2010 and May 2021. After screening, 32 patients met the inclusion criteria for a presumed diagnosis of reversible cerebral vasoconstriction syndrome with both angiography on presentation and at three-month follow-up after treatment. Patients were divided into two categories: those with complete angiographic resolution, versus partial or no improvement on follow-up. Clinical and radiographic data were analyzed.ResultsPatients who had partial or no resolution were more likely to have a history of hypertension (<i>p</i> = 0.001), higher systolic blood pressure on admission (<i>p</i> = 0.047), and present with a recurrent thunderclap headache (<i>p</i> = 0.038). Binary logistic regression selected for hypertension (odds ratio [OR] 18.35 [95% CI, 1.37-245.1]) as predictive of not having reversible cerebral vasoconstriction syndrome, as can be seen by partial or no resolution on follow-up angiography (<i>p</i> = 0.028).ConclusionComplete resolution on follow-up angiography is a distinguishing factor of reversible cerebral vasoconstriction syndrome. Our analysis revealed that a history of hypertension is the most significant predictor of confirming that a patient may not have reversible cerebral vasoconstriction syndrome. This is due, in part, to increased atherosclerotic or hypertensive cerebral arterial changes, which can mimic reversible cerebral vasoconstriction syndrome and present as partial or no resolution on angiography.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1280-1284"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiographic Safety and Efficacy of the ReSolv Flow-Diverting Stent in a Rabbit Model. ReSolv 分流支架在兔模型中的血管造影安全性和有效性
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-06-20 DOI: 10.1177/15910199241260896
Rosalie Ea Morrish, Alec T Chunta, Brooke L Belanger, Paige M Croney, M Suheel Abdul Salam, Crista Thompson, Muneer Eesa, John H Wong, Alim P Mitha
{"title":"Angiographic Safety and Efficacy of the ReSolv Flow-Diverting Stent in a Rabbit Model.","authors":"Rosalie Ea Morrish, Alec T Chunta, Brooke L Belanger, Paige M Croney, M Suheel Abdul Salam, Crista Thompson, Muneer Eesa, John H Wong, Alim P Mitha","doi":"10.1177/15910199241260896","DOIUrl":"10.1177/15910199241260896","url":null,"abstract":"<p><p>BackgroundBioresorbable polymer-based flow-diverting stents have potential benefits over existing metal devices. This study aimed to evaluate the safety and efficacy of the novel ReSolv device, which is a primarily polymer-based flow-diverting stent, using the in vivo rabbit sidewall saccular aneurysm model.MethodsReSolv stents were deployed in 14 New Zealand White rabbits that had undergone aneurysm creation procedures. Animals were allocated to follow-up time points of 1, 3, 6, 9, 12, 16, or 18 months. Angiographic images were evaluated by an independent neurointerventionalist blinded to follow-up time points for (1) in-stent stenosis, (2) parent vessel and jailed side branch patency, (3) wall apposition, and (4) aneurysm occlusion using the Raymond-Roy Occlusion Classification (RROC), O'Kelly Marotta grading scale, and the 4F flow diversion predictive score. Primary efficacy outcome was defined as RROC Class I or II.ResultsAt a median follow-up time of 7.5 months, parent vessel (14/14) and jailed side (33/33) branches were patent in all cases. There was no development of thrombus on the stent or cases of significant in-stent stenosis, and all stents had good wall apposition. Adequate occlusion was found in 85.7% (<i>n</i> = 12) of animals, including an RROC Class I in 64.3% (<i>n</i> = 9) and RROC Class II in 21.4% (<i>n</i> = 3).ConclusionsThe ReSolv stent shows encouraging angiographic safety and efficacy outcomes after placement in a rabbit sidewall saccular aneurysm model. Longer term studies are ongoing to determine eventual fate of the aneurysm, parent vessel, and jailed side branches after absorption of the polymer component of the stent.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1904-1910"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of intracranial aneurysms with large-diameter (≥5.5 mm) Derivo Embolization Devices, with particular focus on 7 and 8 mm diameter devices. 使用大直径(≥5.5 毫米)Derivo 栓塞设备治疗颅内动脉瘤,特别关注直径为 7 毫米和 8 毫米的设备。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-05-05 DOI: 10.1177/15910199241248479
Lukas Goertz, David Zopfs, Jonathan Kottlors, Lenhard Pennig, Stefan Schob, Marc Schlamann, Christoph Kabbasch
{"title":"Treatment of intracranial aneurysms with large-diameter (≥5.5 mm) Derivo Embolization Devices, with particular focus on 7 and 8 mm diameter devices.","authors":"Lukas Goertz, David Zopfs, Jonathan Kottlors, Lenhard Pennig, Stefan Schob, Marc Schlamann, Christoph Kabbasch","doi":"10.1177/15910199241248479","DOIUrl":"10.1177/15910199241248479","url":null,"abstract":"<p><p>ObjectiveThere are few studies on flow diverters with diameters >5 mm. We present our preliminary experience with the 5.5-8 mm Derivo Embolization Device (DED) implants for the treatment of cerebral aneurysms.MethodsA consecutive series of 26 patients (median age: 60 years) treated for 32 aneurysms in 26 procedures was retrospectively analyzed for procedural characteristics, complications, and mid-term angiographic results.ResultsThe median aneurysm size was 10.5 mm, 2 of 30 (6%) aneurysms were ruptured and 9 (28%) had a fusiform or dissecting morphology. DED implantation was performed in the internal carotid artery in 18 of 26 (69%) procedures and in the vertebrobasilar artery in 8 (31%). Device deployment failed in 1 (4%) procedure. The 7 and 8 mm implants were successfully deployed in 5 cases. Additional balloon angioplasty or stent implantation was performed in 3 (12%) cases to improve wall apposition. Complications included 1 (4%) major stroke and 2 (8%) minor strokes. Angiographic follow up at a mean of 6 months showed complete occlusion in 8 of30 (27%) aneurysms and favorable occlusion in 14 (47%).ConclusionsThe use of large diameter DEDs was safe and feasible. The mid-term occlusion rates are acceptable considering the complex subset of aneurysms studied. Further studies are warranted to define the indications for large-diameter DEDs and to evaluate their long-term efficacy.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1455-1463"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of artificial intelligence in brain arteriovenous malformations: Angioarchitectures, clinical symptoms and prognosis prediction. 人工智能在脑动静脉畸形中的应用:血管结构、临床症状和预后预测。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-03-22 DOI: 10.1177/15910199241238798
Xiangyu Li, Sishi Xiang, Guilin Li
{"title":"Application of artificial intelligence in brain arteriovenous malformations: Angioarchitectures, clinical symptoms and prognosis prediction.","authors":"Xiangyu Li, Sishi Xiang, Guilin Li","doi":"10.1177/15910199241238798","DOIUrl":"10.1177/15910199241238798","url":null,"abstract":"<p><p>BackgroundArtificial intelligence (AI) has rapidly advanced in the medical field, leveraging its intelligence and automation for the management of various diseases. Brain arteriovenous malformations (AVM) are particularly noteworthy, experiencing rapid development in recent years and yielding remarkable results. This paper aims to summarize the applications of AI in the management of AVMs management.MethodsLiteratures published in PubMed during 1999-2022, discussing AI application in AVMs management were reviewed.ResultsAI algorithms have been applied in various aspects of AVM management, particularly in machine learning and deep learning models. Automatic lesion segmentation or delineation is a promising application that can be further developed and verified. Prognosis prediction using machine learning algorithms with radiomic-based analysis is another meaningful application.ConclusionsAI has been widely used in AVMs management. This article summarizes the current research progress, limitations and future research directions.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1920-1934"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Affecting Selection of TraineE for Neurointervention (FASTEN). 影响神经干预 TraineE 选择的因素 (FASTEN)。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-02-22 DOI: 10.1177/15910199241232726
Mohamed Elfil, Rami Z Morsi, Sherief Ghozy, Ahmed Elmashad, Adnan Siddiqui, Alhamza R Al-Bayati, Ali Alaraj, Allan Brook, Anthony W Kam, Arindam Rano Chatterjee, Athos Patsalides, Ben Waldau, Charles J Prestigiacomo, Charles Matouk, Clemens M Schirmer, David Altschul, David T Parrella, Gabor Toth, Gaurav Jindal, Hamza A Shaikh, Jaydevsinh N Dolia, Johanna T Fifi, Justin F Fraser, Justin Thomas DO, Krishna Amuluru, Louis J Kim, Mark Harrigan, Matthew R Amans, Max Kole, Max Mokin, Michael Abraham, Mouhammad Jumaa, Nazli Janjua, Osama Zaidat, Patrick P Youssef, Priyank Khandelwal, Qingliang Tony Wang, Ramesh Grandhi, Ricardo Hanel, Ryan T Kellogg, Santiago Ortega-Gutierrez, Sunil Sheth, Thanh N Nguyen, Viktor Szeder, Yin C Hu, Albert J Yoo, Omar Tanweer, Brian Jankowitz, Jeremy J Heit, Richard Williamson, Tareq Kass-Hout, Richard W Crowley, Mohammad El-Ghanem, Fawaz Al-Mufti
{"title":"Factors Affecting Selection of TraineE for Neurointervention (FASTEN).","authors":"Mohamed Elfil, Rami Z Morsi, Sherief Ghozy, Ahmed Elmashad, Adnan Siddiqui, Alhamza R Al-Bayati, Ali Alaraj, Allan Brook, Anthony W Kam, Arindam Rano Chatterjee, Athos Patsalides, Ben Waldau, Charles J Prestigiacomo, Charles Matouk, Clemens M Schirmer, David Altschul, David T Parrella, Gabor Toth, Gaurav Jindal, Hamza A Shaikh, Jaydevsinh N Dolia, Johanna T Fifi, Justin F Fraser, Justin Thomas DO, Krishna Amuluru, Louis J Kim, Mark Harrigan, Matthew R Amans, Max Kole, Max Mokin, Michael Abraham, Mouhammad Jumaa, Nazli Janjua, Osama Zaidat, Patrick P Youssef, Priyank Khandelwal, Qingliang Tony Wang, Ramesh Grandhi, Ricardo Hanel, Ryan T Kellogg, Santiago Ortega-Gutierrez, Sunil Sheth, Thanh N Nguyen, Viktor Szeder, Yin C Hu, Albert J Yoo, Omar Tanweer, Brian Jankowitz, Jeremy J Heit, Richard Williamson, Tareq Kass-Hout, Richard W Crowley, Mohammad El-Ghanem, Fawaz Al-Mufti","doi":"10.1177/15910199241232726","DOIUrl":"10.1177/15910199241232726","url":null,"abstract":"<p><p>Background and importanceNeurointervention is a very competitive specialty in the United States due to the limited number of training spots and the larger pool of applicants. The training standards are continuously updated to ensure solid training experiences. Factors affecting candidate(s) selection have not been fully established yet. Our study aims to investigate the factors influencing the selection process.MethodsA 52-question survey was distributed to 93 program directors (PDs). The survey consisted of six categories: (a) Program characteristics, (b) Candidate demographics, (c) Educational credentials, (d) Personal traits, (e) Research and extracurricular activities, and (f) Overall final set of characteristics. The response rate was 59.1%. As per the programs' characteristics, neurosurgery was the most involved specialty in running the training programs (69%). Regarding demographics, the need for visa sponsorship held the greatest prominence with a mean score of 5.9 [standard deviation (SD) 2.9]. For the educational credentials, being a graduate from a neurosurgical residency and the institution where the candidate's residency training is/was scored the highest [5.4 (SD = 2.9), 5.4 (SD = 2.5), respectively]. Regarding the personal traits, assessment by faculty members achieved the highest score [8.9 (SD = 1)]. In terms of research/extracurricular activities, fluency in English had the highest score [7.2 (SD = 1.9)] followed by peer-reviewed/PubMed-indexed publications [6.4 (SD = 2.2)].ConclusionOur survey investigated the factors influencing the final decision when choosing the future neurointerventional trainee, including demographic, educational, research, and extracurricular activities, which might serve as valuable guidance for both applicants and programs to refine the selection process.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1253-1260"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal function affects the safety and efficacy of tirofiban in acute ischemic stroke thrombectomy patients. 肾功能会影响急性缺血性脑卒中血栓切除术患者服用替罗非班的安全性和有效性。
IF 1.9 4区 医学
Interventional Neuroradiology Pub Date : 2026-08-01 Epub Date: 2024-05-31 DOI: 10.1177/15910199241256682
Linan Qiu, Ye Zhang, Dandan Geng, Yuesong Pan, Xueqian Xu, Jiahao Chen, Minjie Xu, Liuzhu Chen, Yujie Tu, Yezhi Huang, Jingfang Long, Qi Duan, Beilan Wu, Huihua Qiu, Jincai He
{"title":"Renal function affects the safety and efficacy of tirofiban in acute ischemic stroke thrombectomy patients.","authors":"Linan Qiu, Ye Zhang, Dandan Geng, Yuesong Pan, Xueqian Xu, Jiahao Chen, Minjie Xu, Liuzhu Chen, Yujie Tu, Yezhi Huang, Jingfang Long, Qi Duan, Beilan Wu, Huihua Qiu, Jincai He","doi":"10.1177/15910199241256682","DOIUrl":"10.1177/15910199241256682","url":null,"abstract":"<p><p>BackgroundAcute ischemic stroke poses a significant health threat, and thrombectomy has become a routine treatment. Tirofiban has emerged as a promising adjunct therapy to minimize reocclusion after thrombectomy. We aimed to investigate whether renal function influences the safety and efficacy of tirofiban in patients undergoing endovascular therapy.MethodsPatients' clinical data collected from the stroke unit were analyzed. The modified Rankin scale score and symptomatic intracranial hemorrhage (sICH) were used as outcome measures.ResultsA total of 409 patients (mean age: 66.5 years, 292 males [71.4%]) were included. Tirofiban significantly improved 3-month functional outcomes (adjusted odds ratio [aOR] = 2.408, 95% confidence interval [CI] 1.120-5.175), reduced 3-month mortality (aOR = 0.364, 95% CI 0.155-0.856), and decreased the incidence of sICH (aOR = 0.339, 95% CI 0.149-0.767) in patients with estimated glomerular filtration rate (eGFR) ≥ 90 mL/min/1.73 m². However, no significant improvement in prognosis was observed with tirofiban in patients with eGFR < 90 mL/min/1.73 m². Interaction analysis suggested a potential influence of renal function on tirofiban efficacy.ConclusionRenal function may impact the efficacy of tirofiban. Administration of tirofiban in direct thrombectomy patients with normal renal function is safe and improves prognosis. However, the prognostic benefits of tirofiban are limited in patients with impaired renal function.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"1531-1538"},"PeriodicalIF":1.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书